10x Genomics Reports Third Quarter 2022 Financial Results

PLEASANTON, Calif., Nov. 2, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the third quarter ended September 30, 2022. Recent Highlights Revenue was $131.1 million for the third quarter, representing a 5% increase over the corresponding period...

Click to view original post